- Lobbying
- Lobbying by Benaroya Research Institute
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Omar Franco | Chief of Staff, Congressman M. Diaz-Balart |
John Little | Chief of Staff, Senator Martinez |
T.J. Petrizzo | n/a |
Justin LeBlanc | n/a |
Justin LeBlan | n/a |
Tricia Barrentine Guay | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medical
Defense
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Defense
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Defense
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Defense
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Defense
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Secure federal funding for The Center for Control of Inflammation and Tissue Repair (CITR) and a new Cytoprotection Program within the CITR to address mechanisms which protect cells from damage associated with anoxia and inflammation..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate